Shares of Xcerra Corp. (NASDAQ:XCRA) saw an uptick in trading volume on Wednesday . 335,896 shares were traded during mid-day trading, an increase of 66% from the previous session’s volume of 202,334 shares.The stock last traded at $5.99 and had previously closed at $5.96.

Several research firms recently weighed in on XCRA. Zacks Investment Research cut shares of Xcerra Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, August 10th. B. Riley restated a “buy” rating and issued a $8.25 price objective on shares of Xcerra Corp. in a research report on Sunday, June 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of Xcerra Corp. in a research report on Tuesday, June 7th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $8.69.

The company’s 50 day moving average is $5.92 and its 200 day moving average is $5.94. The firm has a market capitalization of $320.61 million and a P/E ratio of 28.25.

In related news, VP Pascal Ronde sold 30,000 shares of the stock in a transaction that occurred on Thursday, June 9th. The shares were sold at an average price of $6.63, for a total transaction of $198,900.00. Following the sale, the vice president now owns 221,250 shares in the company, valued at approximately $1,466,887.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Xcerra Corporation, formerly LTX-Credence Corporation, is engaged in providing test and handling capital equipment, interface products, test fixtures and related services to the semiconductor and electronics manufacturing industries. The Company operates through six segments: Semiconductor Test, Semiconductor Handlers, Contactors, Printed Circuit Board (PCB) Test, Probes/Pins and Fixtures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.